Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

MEG3-miRNAs help control wool traits in young Tan sheep by regulating immune responses, but their decline with age leads to wool changes.

Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.

Targeting pyroptosis may offer new treatments for alopecia areata, but more research is needed.

Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Iron chelators can effectively reduce hair loss and improve hair growth in autoimmune alopecia.

Alopecia areata causes hair loss due to immune issues, and while new treatments show promise, no universally effective solution exists yet.

Cholesterol helps hair grow by activating nerves and boosting hair follicle stem cells.

Hair follicles are key to treating vitiligo and alopecia areata, but challenges exist.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Different stem cells are key for hair growth and health, and understanding their regulation could help treat hair loss.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Silibinin may help hair growth and treat hair loss.

lncRNAs play a key role in hair follicle development, affecting cashmere quality and yield.

Dkk genes evolved faster in birds and reptiles, affecting hair development functions.

Natural products may help treat skin inflammation from abnormal adrenal hormones.